The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.

Journal Article (Journal Article;Review)

OBJECTIVES: To describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center. METHODS: We performed a retrospective review of patients with MOG antibodies. RESULTS: We review the clinical presentation of 11 patients with MOG antibodies. In patients seen at Duke University Health System with MOG antibodies, the most common presentation was optic neuritis. Rituximab was the most used treatment for long-term management. CONCLUSIONS: Our case series highlights the common presentation of MOG antibody disease (MOG-AD) at a single academic medical center.

Full Text

Duke Authors

Cited Authors

  • Brayo, P; Hartsell, FL; Skeen, M; Morgenlander, J; Eckstein, C; Shah, S

Published Date

  • December 15, 2019

Published In

Volume / Issue

  • 337 /

Start / End Page

  • 577078 -

PubMed ID

  • 31671362

Electronic International Standard Serial Number (EISSN)

  • 1872-8421

Digital Object Identifier (DOI)

  • 10.1016/j.jneuroim.2019.577078


  • eng

Conference Location

  • Netherlands